Referring to a pharmaceutically acceptable Salt of ansolvato noribogainano, where this is a Crystalline hydrochloride Salt and Salt, with Peaks of x-ray Powder diffraction 11,6\ufffd selected, 12,1\ufffd, 13,5\ufffd, 14,9\ufffd, 15,7\ufffd, 17,1\ufffd, 17,9\ufffd, 18,3\ufffd, 19,8\ufffd, 20,8\ufffd, 21,0\ufffd 21,9\ufffd 22,8\ufffd 23,3\ufffd,,,, 24,9\ufffd, 25,9\ufffd, 26,4\ufffd, 29,3\ufffd and 29,8\ufffd (+ \/ - 0,2\ufffd 2 Theta).It also relates to a Pharmaceutical composition. These compounds are useful in the treatment of PainREFERIDA A UNA SAL FARMACEUTICAMENTE ACEPTABLE DE ANSOLVATO DE NORIBOGAINANO, DONDE DICHA SAL ES UNA SAL CLORHIDRATO Y CRISTALINA, QUE PRESENTA PICOS DE DIFRACCION DE POLVOS DE RAYOS X SELECCIONADOS DE 11,6�, 12,1�, 13,5�, 14,9�, 15,7�, 17,1�, 17,9�, 18,3�, 19,8�, 20,8�, 21,0�, 21,9�, 22,8�, 23,3�, 24,9�, 25,9�, 26,4�, 29,3� Y 29,8� (+/- 0,2� 2 THETA). TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DEL DOLOR
